Pantheris Biotech
Next-Generation Endosomal Release Peptide Platform
Intracellular delivery is the major bottleneck for modern therapeutics. Our peptide PM3 provides a safe, effective, and versatile solution.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Pantheris Biotech
Next-Generation Endosomal Release Peptide Platform
Headquarter:
Geneva
